Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionsyntaxin-1 binding

NSF UNC13C

3.76e-0424242GO:0017075
GeneOntologyMolecularFunctionchromatin-protein adaptor activity

NBN EPC1

1.10e-0341242GO:0140463
Domain-

CCAR1 HNRNPU

3.00e-04212321.10.720.30
DomainSAP

CCAR1 HNRNPU

3.30e-0422232PF02037
DomainSAP

CCAR1 HNRNPU

3.61e-0423232SM00513
DomainSAP

CCAR1 HNRNPU

4.28e-0425232PS50800
DomainSAP_dom

CCAR1 HNRNPU

4.28e-0425232IPR003034
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

AAK1 CCAR1 NSF PRRC2C ZFR ANKFY1 HNRNPU

2.80e-0696324728671696
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

AAK1 CCAR1 PRRC2C ZFR HNRNPU

4.18e-0636024533111431
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

AAK1 CCAR1 NBN PRRC2C ZFR R3HDM1

7.79e-0672424636232890
Pubmed

Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.

CCAR1 ACBD3 NBN HNRNPU

8.07e-0618824429721183
Pubmed

Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.

ACBD3 NBN PRRC2C ZFR ANKFY1

2.80e-0553424535032548
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

AAK1 ACBD3 NBN PRRC2C ZFR HNRNPU

3.28e-0593424633916271
Pubmed

mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.

CCAR1 ZFR HNRNPU R3HDM1

3.54e-0527424434244482
Pubmed

Human transcription factor protein interaction networks.

CCAR1 NBN PRRC2C ZFR SS18L1 EPC1 R3HDM1

3.64e-05142924735140242
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

CCAR1 NBN PRRC2C ZFR SS18L1 HNRNPU

3.70e-0595424636373674
Pubmed

Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders.

ZFR ENTPD1

4.77e-051524224482476
Pubmed

An improved smaller biotin ligase for BioID proximity labeling.

ZFP36L2 PRRC2C CCDC168

8.27e-0512324326912792
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DISP2 PRRC2C ANKFY1 R3HDM1

1.63e-0440724412693553
Pubmed

A protein-RNA interaction atlas of the ribosome biogenesis factor AATF.

CCAR1 PRRC2C ZFR

1.87e-0416224331363146
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

CCAR1 PRRC2C ZFR HNRNPU R3HDM1

1.96e-0480724522681889
Pubmed

Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation.

CCAR1 ANKFY1 HNRNPU

2.23e-0417224323184937
Pubmed

RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation.

HNRNPU EPC1

2.83e-043624217573780
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

AAK1 MBD5 CCAR1 ASTN2 HNRNPU ENTPD1

4.22e-04148924628611215
Pubmed

Proteome analysis of the HIV-1 Gag interactome.

PRRC2C ZFR

4.24e-044424225010285
Pubmed

The N-terminal domain of the Schaaf-Yang syndrome protein MAGEL2 likely has a role in RNA metabolism.

PRRC2C HNRNPU

4.64e-044624234265304
Pubmed

Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.

CCAR1 ANKFY1 R3HDM1

4.70e-0422224335941108
Pubmed

Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.

PRRC2C ZFR HNRNPU

4.77e-0422324320020773
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

PRRC2C ZFR ANKFY1 HNRNPU

5.15e-0455124434728620
Pubmed

The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.

CCAR1 ZFP36L2 ACBD3 ZFR R3HDM1

5.41e-04100724534597346
Pubmed

Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.

PRRC2C HNRNPU

5.93e-045224226265008
Pubmed

Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.

NSF ZFR HNRNPU

5.97e-0424124323125841
Pubmed

Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.

CCAR1 ZFR HNRNPU

6.19e-0424424329884807
Pubmed

SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.

CCAR1 PRRC2C ZFR

6.72e-0425124331076518
InteractionCELF1 interactions

CCAR1 PRRC2C ZFR HNRNPU R3HDM1

1.57e-05288235int:CELF1
InteractionALG13 interactions

CCAR1 PRRC2C ZFR R3HDM1

5.09e-05183234int:ALG13
InteractionAATF interactions

CCAR1 PRRC2C ZFR SS18L1 HNRNPU

5.62e-05376235int:AATF
InteractionPLCH2 interactions

ZFP36L2 HNRNPU

8.17e-0512232int:PLCH2
InteractionFXR1 interactions

AAK1 CCAR1 PRRC2C ANKFY1 HNRNPU R3HDM1

8.84e-05679236int:FXR1
GeneFamilyADAM metallopeptidase domain containing|CD molecules

ENTPD1 CD109

2.71e-02394122471
CoexpressionAtlasFacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1

MBD5 CCAR1 ACBD3 BTD ANKFY1 EPC1 R3HDM1

1.76e-05780247Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
ToppCellHippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32

AAK1 NSF DISP2 ZFR

3.33e-061942448aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCellmoderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

AAK1 ZFP36L2 PRRC2C EPC1

3.47e-061962449152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCellFrontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

AAK1 NSF DISP2 ZFR

3.68e-06199244f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AAK1 ZFP36L2 DISP2

6.98e-05150243207fc230d7721149c7afc7970dd56817f52801d8
ToppCell367C-Lymphocytic-ILC|367C / Donor, Lineage, Cell class and subclass (all cells)

ZFP36L2 ASTN2 DISP2

8.46e-05160243f70ec054b6d51c1565e4a257cbe3c9537c0eb09f
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9

MBD5 HNRNPU EPC1

9.43e-0516624332d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCellnormal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

AAK1 ZFP36L2 PRRC2C

1.03e-0417124361318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

AAK1 PRRC2C HNRNPU

1.03e-041712432e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellfacs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SS18L1 HID1 ENTPD1

1.05e-041722436ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCellfacs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SS18L1 HID1 ENTPD1

1.05e-04172243f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCellCOVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients

PRRC2C SS18L1 ANKFY1

1.12e-041762432049767fd591045cfcf5b1071d80798e52843f27
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SS18L1 HID1 R3HDM1

1.14e-04177243ff97398d2adb83063b7c53a264bfae86ea7ea304
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SS18L1 HID1 R3HDM1

1.14e-04177243c6812679aa6522d03bd29144e71c5fae6a92325e
ToppCellnormal-na-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

AAK1 ZFP36L2 PRRC2C

1.16e-04178243fa3585383a1e7da460c88a802aaa81246d681b6b
ToppCellfacs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFP36L2 PRRC2C HNRNPU

1.20e-0418024387fb1fdbc49c808bb5f6fe9fb747057b45fa78d0
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DISP2 HID1 ENTPD1

1.22e-04181243cef034030e6b029a49ae56be37ea1fac1a5c350e
ToppCelldroplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFP36L2 PRRC2C HNRNPU

1.24e-04182243eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCelldroplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFP36L2 PRRC2C HNRNPU

1.26e-0418324328cbf909424f3be4491d49832f0aca0386560814
ToppCelldroplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFP36L2 PRRC2C HNRNPU

1.26e-041832433fa608aa6b119869ec3280dc388dfee57160e63a
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

AAK1 ZFP36L2 PRRC2C

1.28e-04184243bd786db4dc4edae6d5cfc0b69901983dea19f729
ToppCellBrain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.

AAK1 PRRC2C EPC1

1.30e-04185243857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCellSubstantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

AAK1 NSF DISP2

1.32e-041862433f889083fcffe516388e9b03a5e23af2010ced33
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

AAK1 ZFP36L2 HNRNPU

1.34e-04187243e61c1755531469dd3850c9740474b5ad4e0499c1
ToppCellILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

ZFP36L2 NBN PRRC2C

1.36e-041882432156f1bc849ff1cb09ae296d13bedd913ae6b43b
ToppCellrenal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

AAK1 MBD5 UNC13C

1.41e-04190243f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C ZFR R3HDM1

1.43e-0419124360c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C ZFR R3HDM1

1.43e-0419124309db184cb90fe282a14474d7217068c58092c6f8
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C ZFR R3HDM1

1.43e-04191243973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellNS-moderate-d_16-33-Lymphoid-Treg|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

AAK1 ZFP36L2 EPC1

1.45e-0419224348d557071bad80edd3ec6e5ad8dcd97037da9553
ToppCellH1299-infected|H1299 / Cell line, Condition and Strain

AAK1 CCAR1 PRRC2C

1.45e-041922439cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCellfacs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NSF HNRNPU ENTPD1

1.45e-041922431ccc47792edf9ee23501c8e2165d11271636b66a
ToppCellmoderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

AAK1 ZFP36L2 EPC1

1.45e-04192243e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C HNRNPU ENTPD1

1.47e-0419324306b65110db974f4ef90d3511ff34428976a52c9c
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

AAK1 ASTN2 UNC13C

1.47e-04193243c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff
ToppCellfacs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C HNRNPU ENTPD1

1.47e-04193243a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCellThalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32

AAK1 NSF DISP2

1.47e-04193243712a4acd1167e43543950bc819ff11984e6f718d
ToppCellPosterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

AAK1 NSF DISP2

1.47e-04193243b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C HNRNPU ENTPD1

1.47e-041932439c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C HNRNPU ENTPD1

1.47e-04193243b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HID1 ENTPD1 CD109

1.47e-04193243daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCellTCGA-Adrenal-Primary_Tumor-Pheochromocytoma|TCGA-Adrenal / Sample_Type by Project: Shred V9

ASTN2 DISP2 HID1

1.49e-04194243b6488bc3a8905e926ad298332963e1bbaf010046
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

AAK1 ASTN2 UNC13C

1.49e-0419424383863da11dfbe59b2d0a2c08db40b537c150588c
ToppCellTCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma|TCGA-Adrenal / Sample_Type by Project: Shred V9

ASTN2 DISP2 HID1

1.49e-041942431e1f4139ad584f493d75a9b7f1568eca4653c5a2
ToppCellControl-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class

ZFP36L2 HNRNPU ENTPD1

1.52e-041952430fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

AAK1 ZFP36L2 UNC13C

1.52e-04195243d70b49f6b9c6c4422adb2936c837a1af7569fb0a
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ZFP36L2 HNRNPU ENTPD1

1.52e-04195243cb27f6ca8b02438c353c9dff2f76d2656bb5b29a
ToppCellnormal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

AAK1 ZFP36L2 PRRC2C

1.54e-04196243feb1c768cf66c64b6c892905d2d865946e70812f
ToppCellfrontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

AAK1 NSF DISP2

1.54e-04196243de7d10da862f98894ce47244fbc992f4a12d63bb
ToppCell10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ZFP36L2 PRRC2C HNRNPU

1.54e-04196243ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de
ToppCellControl-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class

ZFP36L2 PRRC2C HNRNPU

1.56e-04197243eb7610c9496a95a5fd866e16abcbc39b83abe617
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZFP36L2 PRRC2C EPC1

1.56e-04197243ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AAK1 PRRC2C HNRNPU

1.56e-0419724357ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCellmoderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

AAK1 ZFP36L2 PRRC2C

1.59e-041982430a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCellPBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZFP36L2 PRRC2C HNRNPU

1.59e-04198243dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCellSepsis-URO-Lymphocyte-T/NK-CD4+_CTL|URO / Disease, condition lineage and cell class

AAK1 ZFP36L2 ASTN2

1.59e-04198243c53405a8d082fbd10131a6ec88b69fdd835f2925
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ZFP36L2 PRRC2C EPC1

1.59e-0419824333a3b279c9ff3b762e52d060dae062167ca2239b
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AAK1 PRRC2C HNRNPU

1.61e-04199243f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellmild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ZFP36L2 PRRC2C EPC1

1.61e-0419924306c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCellsevere|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PRRC2C HNRNPU EPC1

1.63e-04200243accc618d6b960bff30cb531c1226295bfc8650f6
ToppCellmild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

AAK1 ZFP36L2 PRRC2C

1.63e-04200243109f673a4967ffa52270a0b4f818b3461288db44
ToppCell10x_5'_v1-Non-neoplastic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

AAK1 ZFP36L2 HNRNPU

1.63e-0420024388e94b067da1068b2ff1f95c730f2a49c66d7fe6
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type.

MBD5 HID1 CD109

1.63e-042002436b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCellCOVID-19|World / Disease, condition lineage and cell class

PRRC2C HNRNPU EPC1

1.63e-042002437dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

UNC13C CD109

1.66e-03113242feb3c6a7723263d58e5ce020a0097fedfcf78ca8
ToppCellBronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ASTN2 SS18L1

1.75e-03116242b0a3c109c5f20ab699e53bf8ab3903d102f5f315
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

UNC13C CCDC168

1.84e-031192428eefcf1ace62ad1c90fa5b62ec159c83ec527bf3
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DISP2 CCDC168

2.09e-03127242fbf7e6bea9991628e98f75c279e2992031dcb8db
ToppCell(08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition

PRRC2C ZFR

2.47e-03138242817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ASTN2 CCDC168

2.61e-03142242f720f13b339589fa924a42e89393e5db0b26300b
ToppCellE16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass

PRRC2C HOXA2

2.87e-03149242651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCell3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue

ZFP36L2 PRRC2C

2.94e-03151242999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell367C-Lymphocytic-ILC-ILC-3|367C / Donor, Lineage, Cell class and subclass (all cells)

ZFP36L2 ASTN2

3.02e-031532429d64aadbb4bb28469af1d728457b431e21577429
ToppCell356C-Lymphocytic-ILC-ILC-3|356C / Donor, Lineage, Cell class and subclass (all cells)

ZFP36L2 NSF

3.06e-03154242923f5eb8e9258105dbdbe57a5e7976ef60dae29b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ENTPD1 CD109

3.10e-0315524259035d792c26d870a8b097939e97fa47859ba68c
ToppCell367C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ASTN2 DISP2

3.18e-03157242f511871e1a004c6e9af08ee325ab1bfc41807487
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ENTPD1 CD109

3.18e-0315724210341ed8cbee0f636770a82cf580f6453bee8596
ToppCellStriatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32

ASTN2 DISP2

3.18e-03157242c41ff3fe9de7187575114febfe9bd8733366fb8a
ToppCellLeuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, Lineage and Cell Type

ASTN2 HID1

3.21e-0315824205a29c2d5506a25ccdfa4c6a86e9188977a18272
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HID1 CD109

3.25e-03159242ba82d1f55dd77c4b2183981b76cab1480fba75ad
ToppCell390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

CCDC168 CD109

3.29e-03160242636127753e3a22831f39d4c8170df40901e4329d
ToppCell390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

CCDC168 CD109

3.29e-03160242cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63
ToppCellfacs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MBD5 SS18L1

3.29e-03160242b3f7ef7e682b48a83ca425f5c439336e96168300
ToppCellBronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ASTN2 SS18L1

3.38e-03162242afffecc6c504930554aafc12c5bffa53e3c5b016
ToppCellURO-Lymphocyte-T_NK-CD4_CTL|URO / Disease, Lineage and Cell Type

AAK1 ASTN2

3.38e-031622421afeeb17e263cf625a4f285203cf82f973735193
ToppCell367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells)

ZFP36L2 DISP2

3.38e-0316224274cd0de957fdbe527656befd61f67d6814ce9e98
ToppCellnormal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass

ZFP36L2 PRRC2C

3.38e-0316224291ac35ae7fde411cd6a44e715a33dac62419cab8
ToppCellHealthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass

DISP2 HID1

3.42e-031632422913ccdd4613472cd82077d4993e1d9f8b223398
ToppCellHealthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass

DISP2 HID1

3.42e-03163242b589ff57d58dcb215ee3b5a10d81f43e5752a196
ToppCellwk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

NSF UNC13C

3.46e-03164242583dda853cee9491dbdcb228c23d8deadc20eb08
ToppCellIonocyte-iono-3|World / Class top

ASTN2 ENTPD1

3.54e-031662429c4a780f8af46d7552077c7a0ae0ab1b2413e5d4
ToppCellDendritic_Cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

ZFP36L2 ENTPD1

3.54e-03166242fbeb74b98b58085de323f744b18d4a8f7b22d5d4
ToppCelldroplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SS18L1 HOXA2

3.58e-03167242a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

ENTPD1 CD109

3.58e-03167242ecdbfde870a2a44c44b9dd65a8737afc6fbf816c
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

YIPF7 UNC13C

3.58e-0316724291b14df450bfb6a2b406c88f8c75cd51eeb9e82b
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NBN HOXA2

3.58e-03167242784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCellfacs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ASTN2 YIPF7

3.58e-0316724278909f685ccd1321064eb0887caf9263e0e54879
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SS18L1 HID1

3.58e-03167242d1a13d6ada572d8ddb2da95e6e122d2b705fad7f
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

AAK1 ZFP36L2

3.62e-0316824207be11b6f0f37106e219692db5795c6dd32807c9
ToppCell368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

CD109 HOXA2

3.62e-0316824283b4f817d95daa15ae60668e789f97d8a3b2e6dd
ToppCell368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

CD109 HOXA2

3.62e-03168242c66a61d3ec711796313a2c6d2dc39aedbfc20afd
ComputationalNeighborhood of SMC1L1

PRRC2C HNRNPU R3HDM1

1.40e-0462183MORF_SMC1L1
DrugCalciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A

AAK1 ZFP36L2 BTD ANKFY1 ENTPD1

1.76e-061982455346_UP
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A

ACBD3 NBN PRRC2C ZFR

3.40e-051782443998_DN
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A

ACBD3 NBN PRRC2C ZFR

3.47e-051792444585_DN
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

ACBD3 NBN PRRC2C ZFR

4.20e-051882446735_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

ACBD3 NBN PRRC2C ZFR

4.29e-051892441045_DN
DrugPropantheline bromide [50-34-0]; Down 200; 9uM; MCF7; HT_HG-U133A

ZFP36L2 BTD ANKFY1 HNRNPU

4.38e-051902443352_DN
DrugFluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A

ACBD3 PRRC2C ZFR HNRNPU

4.38e-051902444114_DN
Druggenistein; Down 200; 10uM; MCF7; HT_HG-U133A

BTD ANKFY1 HNRNPU ENTPD1

4.66e-051932445232_DN
DrugNifuroxazide [965-52-6]; Down 200; 14.6uM; PC3; HT_HG-U133A

AAK1 ZFP36L2 ANKFY1 R3HDM1

4.66e-051932444253_DN
DrugCP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A

ZFP36L2 ACBD3 HNRNPU ENTPD1

4.66e-051932443906_DN
DrugSalsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; PC3; HT_HG-U133A

ZFP36L2 ASTN2 BTD ANKFY1

4.75e-051942444232_DN
DrugFlutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

ZFP36L2 ACBD3 NBN PRRC2C

4.75e-051942444361_DN
Drug0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A

AAK1 ZFP36L2 BTD ANKFY1

4.75e-051942443774_DN
DrugMegestrol acetate [595-33-5]; Down 200; 10.4uM; PC3; HT_HG-U133A

ZFP36L2 ASTN2 HNRNPU ENTPD1

4.75e-051942446667_DN
DrugLY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A

ASTN2 BTD HNRNPU ENTPD1

4.85e-051952445213_DN
DrugProgesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A

ZFP36L2 BTD HNRNPU ENTPD1

4.85e-051952442426_UP
DrugEthisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A

ACBD3 ASTN2 ZFR HNRNPU

4.85e-051952443864_DN
DrugICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A

AAK1 ZFP36L2 BTD HNRNPU

4.95e-051962441146_DN
DrugTetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A

AAK1 BTD HNRNPU ENTPD1

4.95e-051962445728_DN
Drugpentamidine isethionate salt; Down 200; 100uM; MCF7; HG-U133A

BTD PRRC2C ZFR HNRNPU

5.04e-05197244639_DN
DrugProbucol [23288-49-5]; Down 200; 7.8uM; PC3; HT_HG-U133A

ASTN2 BTD HNRNPU ENTPD1

5.04e-051972444666_DN
DrugHexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; PC3; HT_HG-U133A

AAK1 ASTN2 HNRNPU ENTPD1

5.04e-051972446620_DN
DrugAmiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A

ASTN2 BTD ANKFY1 ENTPD1

5.04e-051972441470_DN
DrugNadolol [42200-33-9]; Down 200; 13uM; PC3; HT_HG-U133A

ZFP36L2 ASTN2 BTD ENTPD1

5.14e-051982444021_DN
DrugHyoscyamine (L) [101-31-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A

ZFP36L2 ENTPD1 R3HDM1 HOXA2

5.14e-051982445524_UP
Drug5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA

ZFP36L2 ASTN2 BTD PRRC2C

5.14e-05198244889_DN
DrugHydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A

AAK1 ZFR ENTPD1 R3HDM1

5.14e-051982444282_DN
DrugDyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A

AAK1 ZFP36L2 BTD HNRNPU

5.14e-051982442392_DN
Drug3-methylcrotonylglycine

NBN BTD

1.11e-0415242CID000169485
DrugBIPM

NSF CD109

1.61e-0418242CID000117909
Drugtestosterone enanthate

ACBD3 ASTN2 BTD PRRC2C ENTPD1

2.88e-04575245ctd:C004648
DrugN en

NSF NBN

5.18e-0432242CID000016842
Drugethoxyformic anhydride

NSF NBN

6.20e-0435242CID000007766
DrugIci 174864

NSF NBN

6.20e-0435242CID000107691
Drug6-6 PBG

NSF NBN

6.56e-0436242CID015954289
Drug3-methylcrotonyl-CoA

NBN BTD

6.56e-0436242CID000000099
DrugTerbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; PC3; HT_HG-U133A

ZFP36L2 ENTPD1 R3HDM1

9.13e-041832435764_UP
DrugAdiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A

AAK1 ZFP36L2 ZFR

9.13e-041832431709_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ZFP36L2 NBN ZFR

9.13e-041832434770_DN
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A

ACBD3 PRRC2C ZFR

9.42e-041852431673_DN
Drugsuccinylacetone

NBN BTD

9.81e-0444242CID000005312
DrugPrimaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

ZFP36L2 PRRC2C ZFR

9.87e-041882434845_DN
DrugCP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A

AAK1 ASTN2 BTD

1.00e-031892437537_UP
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

ZFP36L2 BTD HNRNPU

1.00e-031892435203_DN
DrugDisopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A

ZFP36L2 ANKFY1 HNRNPU

1.02e-031902437439_DN
DrugEconazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A

ZFP36L2 BTD ANKFY1

1.02e-031902437305_DN
DrugKawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A

NBN ZFR HNRNPU

1.02e-031902432299_DN
Drugcolchicine; Up 200; 1uM; SKMEL5; HG-U133A

AAK1 ZFP36L2 PRRC2C

1.02e-03190243630_UP
DrugPromazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A

BTD ANKFY1 HNRNPU

1.02e-031902433833_DN
Drug3-hydroxyisovaleric acid

NBN BTD

1.03e-0345242CID000069362
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A

NBN ASTN2 ZFR

1.03e-031912434279_DN
DrugAzathymine, 6 [932-53-6]; Down 200; 31.4uM; HL60; HT_HG-U133A

AAK1 ZFR ENTPD1

1.03e-031912432466_DN
DrugCP-944629 [668990-94-1]; Down 200; 10uM; PC3; HT_HG-U133A

ZFP36L2 BTD ANKFY1

1.03e-031912437549_DN
DrugPiperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A

AAK1 ZFP36L2 ENTPD1

1.03e-031912433574_UP
Drug0393-0188; Up 200; 10uM; PC3; HT_HG-U133A

AAK1 ZFP36L2 BTD

1.05e-031922437536_UP
Drug2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A

ZFP36L2 NBN ENTPD1

1.05e-031922435206_DN
DrugRescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A

ZFP36L2 NBN BTD

1.05e-031922432785_DN
DrugProguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A

AAK1 BTD HNRNPU

1.05e-031922433505_DN
DrugCyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A

PRRC2C ZFR HNRNPU

1.05e-031922433252_DN
DrugBerberine chloride [633-65-8]; Down 200; 10.8uM; HL60; HG-U133A

ZFR SS18L1 HNRNPU

1.05e-031922431778_DN
DrugTropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A

ASTN2 ZFR ENTPD1

1.06e-031932434280_DN
DrugZaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A

AAK1 ZFP36L2 HNRNPU

1.06e-031932436749_DN
DrugHaloperidol [52-86-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A

AAK1 ZFP36L2 BTD

1.06e-031932435273_DN
DrugHeptaminol hydrochloride [543-15-7]; Up 200; 22uM; MCF7; HT_HG-U133A

ZFP36L2 ZFR HNRNPU

1.06e-031932431703_UP
DrugHydrochlorothiazide [58-93-5]; Down 200; 13.4uM; PC3; HT_HG-U133A

AAK1 ASTN2 ENTPD1

1.06e-031932436625_DN
DrugQuercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

AAK1 ZFP36L2 ZFR

1.06e-031932434846_DN
DrugEucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

ZFP36L2 ACBD3 HNRNPU

1.06e-031932433841_DN
DrugNocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A

AAK1 NBN ZFR

1.06e-031932432076_DN
DrugEpivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A

AAK1 ZFP36L2 ENTPD1

1.08e-031942432775_UP
Diseaseascending aortic diameter

MBD5 DISP2 ENTPD1

1.97e-04140243EFO_0021787
Diseasesubiculum volume

NSF ASTN2

5.61e-0443242EFO_0009399
Diseasefeeling emotionally hurt measurement

MBD5 NSF

9.51e-0456242EFO_0009599
Diseaseobstructive sleep apnea

NSF R3HDM1

1.32e-0366242EFO_0003918
Diseasemigraine disorder, Headache

NSF ASTN2

2.22e-0386242HP_0002315, MONDO_0005277
Diseasefeeling nervous measurement

MBD5 NSF

2.27e-0387242EFO_0009597
Diseaseresponse to vaccine

ASTN2 UNC13C

4.41e-03122242EFO_0004645
DiseaseIntellectual Disability

NSF HNRNPU ENTPD1

5.52e-03447243C3714756
DiseaseParkinson's disease (implicated_via_orthology)

AAK1 NSF

7.19e-03157242DOID:14330 (implicated_via_orthology)
Diseaseepilepsy (implicated_via_orthology)

NSF UNC13C

7.73e-03163242DOID:1826 (implicated_via_orthology)
Diseasecreatinine measurement

MBD5 ZFP36L2 ASTN2 PRRC2C

7.97e-03995244EFO_0004518
Diseaseretinal vasculature measurement

AAK1 EPC1 R3HDM1

8.23e-03517243EFO_0010554
Diseaseurinary albumin to creatinine ratio

PRRC2C UNC13C

9.25e-03179242EFO_0007778
Diseaseuterine fibroid

YIPF7 CD109

1.13e-02199242EFO_0000731
Diseaseage at menarche

AAK1 YIPF7 UNC13C

1.20e-02594243EFO_0004703

Protein segments in the cluster

PeptideGeneStartEntry
FAFTAEQYQQHQQQL

EPC1

581

Q9H2F5
AQQQPAGTFYQQQQA

AAK1

481

Q2M2I8
AGTFYQQQQAQTQQF

AAK1

486

Q2M2I8
GGSQQQLMQNFYQQQ

AAK1

521

Q2M2I8
QQQYSQPQQALYSVQ

CCAR1

81

Q8IX12
QFQTNFRNSPDYNQT

DISP2

906

A7MBM2
YNNRTQHVNQGQVFQ

ASTN2

781

O75129
QTGYQVIPNQQQNYQ

R3HDM1

681

Q15032
GVNNNQGVNIFNYQV

ANKFY1

1071

Q9P2R3
KNQSQGYNQWQQGQF

HNRNPU

796

Q00839
FIQQFNNQAFSVGQQ

NSF

121

P46459
NSQTAVQFQQYAAQQ

ACBD3

251

Q9H3P7
FQQFEIQGIGNYQQC

ENTPD1

311

P49961
IQVQVNDQTYYQSFQ

CD109

206

Q6YHK3
RYQFNTNVVFSNNGT

BTD

191

P43251
QQQQLLQGYQNLQAF

MBD5

981

Q9P267
GQNAFQNQGLYEVQF

CCDC168

301

Q8NDH2
QNQGLYEVQFTSQAQ

CCDC168

306

Q8NDH2
REGYTFQQNALSQQQ

HOXA2

246

O43364
ASQQQQTNSIRNYFQ

NBN

446

O60934
FNNIIQYQFDGNSNL

HID1

536

Q8IV36
VQQPGQTNFYNTAQS

PRRC2C

2561

Q9Y520
AAQQQTYSQQQYPSQ

SS18L1

321

O75177
VQAQYSTAGFVQQSN

nan

216

Q6ZSR9
YQGANSNELYQNQNQ

UNC13C

741

Q8NB66
ASSYYQQQQQQQKQA

ZFR

276

Q96KR1
YQSNFTIDNQEQSGN

YIPF7

36

Q8N8F6
VAAAAYYRSQQQQQQ

ZFP36L2

386

P47974